Alzheimer's disease is the most common cause of dementia in the elderly. Al
though several genetic defects have been identified in patients with a fami
ly history of this disease, the majority of cases involve individuals with
no known genetic predisposition. A mutant form of ubiquitin, termed Ub(+1),
has been selectively observed in the brains of Alzheimer's patients, inclu
ding those with nonfamilial Alzheimer's disease, but it has been unclear wh
y Ub(+1) expression should be deleterious. Here we show that Ub(+1) is an e
fficient substrate for polyubiquitination in vitro and in transfected human
cells. The resulting polyubiquitin chains are refractory to disassembly by
deubiquitinating enzymes and potently inhibit the degradation of a polyubi
quitinated substrate by purified 26S proteasomes. Thus, expression of Ub(+1
) in aging brain could result in dominant inhibition of the Ub-proteasome s
ystem, leading to neuropathologic consequences.